EU Delays Approval of Novavax’s Revised Covid Jab: FT
This article is for subscribers only.
Want the lowdown on European markets? In your inbox before the open, every day. Sign up here.
EU regulators have delayed a decision to approve Novavax’s variant-tailored Covid-19 vaccine, Financial Times reports.